The Institute of Clinical and Translational Science is collaborating with Venture Café St. Louis in hosting a month of interactive sessions on Thursdays. The theme, “Precision Medicine: From the Lab to Life Hacks,” will be put forth by Washington University faculty engaged in translational genomics and precision medicine research at the cutting edge, with the purpose of creating dialog with students, entrepreneurs, other faculty and the St. Louis community at large.
Precision medicine, the pragmatic facet of translational genomics research, is flexing its muscle. Precision medicine is designed to take into account individual variability in genes, environments, and lifestyle to design prevention and treatment for each person. Recently, Brian Gage, MD, a physician scientist in WUSTL Department of Medicine, published impressive results from a clinical trial evaluating the safety of applying genotype-guided dosing of warfarin to prevent deep venous thrombosis in orthopedic surgery patients. Genotype-guided dosing was correlated to a significant reduction in post-operative hemorrhage. Additional studies are underway to personalize treatment for cancer, cardiac disease, and smoking cessation. These studies are demonstrating the real-world value of genomic medicine, particularly in those populations whose genotype informs their outcome to therapies.
At each Thursday session, focus on existing technologies that employ precision medicine results or principles will help attendees engage with speakers about the opportunities and barriers to moving precision medicine into everyday healthcare. The main event is February 22nd starting at 3:30PM, but there is a precision medicine session every Thursday in February.
February 15, 2018
3:30 – 4:30 PM | Mobile Tools to Asses Health & Wellness
February 22, 2018
3:30-4:30 PM | Artificial Intelligence in Healthcare
4:30 – 5:30 PM | Using RNA to Diagnose Disease
5:30 – 6:30 PM | The Science of Precision Medicine
6:30 – 7:30 PM | The Business of Precision Medicine